Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice.
CONCLUSIONS: Adverse reaction should be recognized by both dermatologists and oncologists and a multidisciplinary approach is mandatory.
PMID: 29756421 [PubMed - as supplied by publisher]
Source: Giornale Italiano di Dermatologia e Venereologia - Category: Dermatology Tags: G Ital Dermatol Venereol Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Dermatology | Erbitux | Italy Health | Skin | Study | Tarceva | Toxicology